Green Thumb Industries Inc. Faces Trading Halt and Resumption

Green Thumb Industries Inc., a pharmaceutical company specializing in medical marijuana and cannabis products, experienced a trading halt and subsequent resumption on April 30, 2025. The company, which operates in the health care sector, saw its trading activities temporarily suspended by the Canadian Investment Regulatory Organization (CIRO) due to a single stock circuit breaker. The halt occurred at 11:57 AM ET and was lifted at 12:02 PM ET, allowing trading to resume shortly after.

The trading halt was part of CIRO’s regulatory measures to ensure fair and orderly trading conditions. Such halts are typically implemented when there is significant volatility in a stock’s price, preventing drastic price movements that could disadvantage investors.

In other news, Green Thumb Industries announced the opening of its 104th retail location, the Rise Dispensary Ocala, in Florida, scheduled for April 29, 2025. This expansion marks a significant milestone for the company, which continues to grow its presence in the United States.

As of April 28, 2025, Green Thumb Industries’ stock was trading at $5.89, down from its 52-week high of $14.318 on May 1, 2024, and above its 52-week low of $4.63 on April 6, 2025. The company’s market capitalization stands at $1.81 billion, with a price-to-earnings ratio of 20.46.

These developments highlight the dynamic nature of Green Thumb Industries’ operations and its ongoing efforts to expand its market reach in the cannabis industry.